Navistar
Device Therapeutic Catheters
PDI 10846835008555
General payments
$26,670
Research payments
$76,806
Through program year 2025, $26,670 in general payments and $76,806 in research payments were reported against Navistar (Therapeutic Catheters).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $11 | 2 |
| 2025 | Research | $34,524 | 1 |
| 2024 | General | $9,306 | 10 |
| 2023 | General | $935 | 16 |
| 2023 | Research | $35,864 | 1 |
| 2022 | General | $15,031 | 44 |
| 2022 | Research | $3,400 | 3 |
| 2021 | General | $1,387 | 8 |
| 2021 | Research | $3,018 | 3 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
80 general · 8 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.